Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucantime dosing frequency in acute anthroponotic cutaneous leishmaniasis
NCT04340128Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2007
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Tehran University of Medical Sciences. Started May 2007; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT04340128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04340128.